Conférences  >  Médecine & Soins de Santé  >  Hématologie

Binaytara Foundation

This CME-accredited oncology conference, BTF's 2024 Updates on Hematology and Oncology, Fresno, is designed to improve the care of cancer patients by educating clinicians involved in cancer care. The expert faculty will present a comprehensive overview of recent updates in hematology and oncology, and practice-changing abstracts from the 2024 American Society of Clinical Oncology Annual Meeting (ASCO2024) held in June 2024. The program will feature in-depth discussions and analyses of the latest scientific discoveries and advancements. Faculty will contextualize these findings within clinical practice and explore their potential to alter current standards of care. This conference is designed for physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other healthcare professionals, providing them with the latest updates in the field. Emphasizing a multidisciplinary approach, it will showcase the integration of new advancements into patient-centered care.

Tél.: [425-616-0572];     Email.: cme@binayfoundation.org

Hematology, Oncology

Cancérologie,    Formation médicale continue (FMC)

Binaytara Foundation

The Southwest Hematology Oncology Conference: Precision Guided Therapy is a 1-day educational and scientific meeting that will focus on the updates in the biomarker-guided management of patients with common malignancies. This conference will feature experts discussing the latest diagnostic, therapeutic, and supportive care strategies in cancer management. In addition, expert faculty will place key abstract findings from the 2024 ASCO Annual Meeting into a clinical context and discuss how the results may change the current standards of care. The goals of this conference are to review and critically assess practice-changing results of practice-changing clinical data and expert recommendations to incorporate biomarker-guided therapy in the management of patients with cancer.

Tél.: [425-616-0572];     Email.: cme@binayfoundation.org

Hematology, Oncology, Precision Guided Therapy, Malignancies

Cancérologie,    Formation médicale continue (FMC)

Binaytara Foundation

This CME-accredited activity, “2024 Seattle Cellular Therapy Summit: Updates and Focus on Accessibility” features leading experts who will provide a comprehensive overview of current and emerging strategies for the management of lymphoma, myeloma, acute leukemias, and solid tumors with a focus in the use of cellular therapies. The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with hematologic malignancies and to describe potential future applications of cellular therapy in solid tumors. The activity will use a mix of didactic lectures and case-based discussions to highlight areas of debate between cellular therapy and non-cellular therapy in the treatment of these diseases. Expert faculty will aim to place the role of different therapeutic agents in a clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care. This conference is designed to provide physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other healthcare professionals with the latest updates in the field. It will highlight a multidisciplinary approach and the integration of new advances in patient-centered care. The faculty will discuss barriers to using cellular therapy and discuss evidence-based strategies to navigate these barriers to incorporate the new standards of care in managing patients with cancer.

Tél.: [425-616-0572];     Email.: cme@binayfoundation.org

Cellular Therapy, Oncology, Hematology, Accessibility, Lymphoma, Myeloma, Acute Leukemia

Cancérologie,    Formation médicale continue (FMC)

Binaytara Foundation

This CME-accredited activity, Wisconsin Multiple Myeloma & Lymphoma Summit, features leading experts in hematologic malignancies who will provide a comprehensive overview of current and emerging strategies for the management of multiple myeloma, lymphoma, and Waldenström Macroglobulinemia. This activity aims to improve learners' knowledge and competence to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with hematologic malignancies. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in newly diagnosed and relapsed multiple myeloma and lymphomas with a focus on emerging immunotherapies, including but not limited to CAR-T therapy and T-cell redirecting bispecific antibodies. Expert faculty will aim to place the role of different therapeutic agents in clinical contexts and discuss how to utilize these therapeutic options to effectively contribute to patient care.

Tél.: [425-616-0572];     Email.: cme@binayfoundation.org

Hematology, Oncology, Myeloma, Lymphoma

Cancérologie,    Formation médicale continue (FMC)

event lab. GmbH

Die immer komplexer werdenden Patientenverläufe erfordern intensive Recherchen und kollegialen Austausch. Einige ausgewählte Fragen werden Schwerpunkt der Fortbildung sein, welche die spezielle Fallvorstellung und einen dazu komplementären Übersichtsvortrag beinhaltet.

Hämatologie, Weiterbildung

Binaytara Foundation

This CME-accredited activity Cellular Therapy in Hematology and Oncology: Expert Guidance for Clinical Practice features leading experts in hematologic malignancies and cellular therapies who will provide a comprehensive overview of current and emerging strategies for the management of lymphoma, myeloma, acute leukemias, and solid tumors with a focus in the use of cellular therapies. The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with hematologic malignancies and to describe potential future applications of cellular therapy in solid tumors. The activity will use a mix of didactic lectures and case-based discussions to highlight areas of debate between cellular therapy and non-cellular therapy in the treatment of these diseases. Expert faculty will aim to place the role of different therapeutic agents in a clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care. This conference is designed to provide physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other healthcare professionals with the latest updates in the field. It will highlight a multidisciplinary approach and the integration of new advances in patient-centered care.

Tél.: [425-616-0572];     Email.: cme@binayfoundation.org

Cellular Therapy, Oncology, Hematology, Lymphoma, Myeloma, Acute Leukemia

Cancérologie,    Formation médicale continue (FMC)

Binaytara Foundation

This CME-accredited activity, Park City Lymphoma Myeloma Conference, features leading experts in hematologic malignancies who will provide a comprehensive overview of current and emerging strategies for the management of multiple myeloma, lymphoma, and Waldenström Macroglobulinemia. This activity aims to improve learners' knowledge and competence to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with hematologic malignancies. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in newly diagnosed and relapsed multiple myeloma and lymphomas with a focus on emerging immunotherapies, including but not limited to CAR-T therapy and T-cell redirecting bispecific antibodies. Expert faculty will aim to place the role of different therapeutic agents in clinical contexts and discuss how to utilize these therapeutic options to effectively contribute to patient care.

Tél.: [425-616-0572];     Email.: cme@binayfoundation.org

Oncology, Hematology, Lymphoma, Myeloma, Waldenström Macroglobulinemia

Formation médicale continue (FMC),    Cancérologie

Binaytara Foundation

This CME-accredited activity 2024 Annual Summit on Hematologic Cancers features leading experts in hematologic malignancies who will provide a comprehensive overview of current and emerging strategies for the management of acute myeloid leukemia, acute lymphoblastic leukemia, chronic lymphocytic leukemia, chronic myeloid leukemia, myeloproliferative neoplasms, multiple myeloma, and lymphoma. The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with hematologic malignancies. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances along with case-based discussion in the field of hematologic malignancies. Expert faculty will aim to place the role of different therapeutic agents in a clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care.

Tél.: [425-616-0572];     Email.: cme@binayfoundation.org

hematology, lymphomas, myeloma,

CME Congresses

The COSTEM Congress is a platform for our community to interact with each other and to share our scientific research, clinical experience, and on-going developments in our field. COSTEM encourages active participation in debate discussions and challenges global experts to promote their positions on a wide range of burning issues – providing clinicians the opportunity to share, express and compare experiences in order to establish and advance effective and reliable patient treatments. COSTEM 2024 will continue to push the envelope and be a progressive, compelling and informative congress, where the most compelling and controversial topics facing clinicians in our field are presented in a fascinating and exciting debate forum.

Event Secretariat;     Email.: costem@cme-congresses.com

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Myeloproliferative Neoplasms, Lymphoma and Myeloma, Non-malignancies, Pediatrics, Autoimmune Diseases, Cell Therapy, cytotoxic T lymphocytes

Medizinisches Zentrallabor – Abteilung Transfusionsmedizin und Klinische Hämostaseologie, Klinik für Hämatologie, Zelltherapie und Hämostaseologie Bereich Hämostaseologie, MVZ Labor Dr. Reising-Ackermann und Kollegen

event lab. GmbH;     Tél.: [0341 30 88 84 62];     Email.: asauerland@eventlab.org

Médecine vasculaire, Angéiologie,    Cancérologie